The Agenda

Agenda – What’s on when

7:30 – 8:25

Registration and Check-in          Meeting Room 203          Philadelphia Convention Center

TRACK 1

TRACK 2

TRACK 1

PRECISION ONCOLOGY

TRACK 2

PM OUTSIDE OF ONCOLOGY

8:25 – 8:30

Welcome and Introduction

8:35 – 9:05

Opening Keynote Address

9:00 – 10:20

TRACK 1

9:00-10:20

Diagnosis to Treatment – A Case Study in NSCLC at MGH/Dana-Farber
Jason Crites

Moderator: Jason Crites, Assurance Health Data

Robert Dumanois

Rob Dumanois, Thermo Fisher Scientific

Joe Lennerz

Joe Lennerz, BostonGene

TRACK 2

9:00-9:20

Scaling Precision Therapeutic Development for Rare DiseaseLandscape Overview
Marni Falk

Marni Falk, CHOP

9:20-9:40

Prognostic Biomarkers and Preclinical Modeling – the Cost of Inaction

Stephen Ekker, University of Texas at Austin

9:40-10:00

Regulator Paths for Rare Disease

Christine Nguyen, FDA

10:00-10:20

Legal/Regulatory for Rare Disease

Frank Sasinowski, Hyman, Phelps & McNamara

10:20 – 10:50

Networking and Exhibits

TRACK 1

TRACK 2

10:50 – 12:50

TRACK 1

10:50-11:50

Who Needs Liquid Biopsy? Opportunities to Increase Access and Improve Outcomes
Nicole St. Jean

Nicole St. Jean, GSK

Phil Febbo, BloodPAC

Andrea Ferreira-Gonzalez, Virginia Commonwealth University

Lauren Lieman, BloodPAC

Lee-Anne Zinetti, Novartis

11:50-12:50

Advancing Digital Pathology and Precision Medicine – Where Are We Now?

Shruti Mathur, Genentech

Luke Benko, Roche Diagnostics

Kimberly Gasaud, Ibex

TRACK 2

10:50-11:10

Real World Data vs Multi Modal Omics Data for Therapeutic Discovery

Adam Resnick, CHOP

11:10-11:30

An Academic Perspective on Rare Disease Target Discovery to Commericial Treatment Development
Hakon Hakonarson

Hakon Hakonarson, CHOP

11:30-11:50

Pharma Perspective and Realities

Sundeep Dugar, Rarefy Therapeutics

11:50-12:10

NCATS Perspective on Success and Failures of Drug Repurposing for Rare Disease

PJ Brooks, NIH

12:10-12:50

A Panel Discussion: Scaling Precision Therapeutic Development for Rare Disease
Marni Falk

Marni Falk, CHOP

Stephen Ekker, University of Texas at Austin

Christine Nguyen, FDA

Frank Sasinowski, Hyman, Phelps & McNamara

Adam Resnick, CHOP

Hakon Hakonarson

Hakon Hakonarson, CHOP

Sundeep Dugar, Rarefy Therapeutics

PJ Brooks, NIH

12:50 – 1:50

Lunch

TRACK 1

TRACK 2

TRACK 1

PRECISION ONCOLOGY continued

TRACK 2

PM OUTSIDE OF ONCOLOGY continued

1:50 – 3:50

TRACK 1

1:50-3:50

Unlocking the Next Quantum Leap in Precision Medicine – A Town Hall Discussion

Co-Chairs

Amanda Paulovich

Amanda Paulovich, Fred Hutchinson Cancer Center

Henry Rodriguez

Henry Rodriguez, NCI/NIH

Eric Schadt

Eric Schadt, Pathos

Participants

Ezra Cohen, Tempus

Jennifer Leib, Innovation Policy Solutions

Susan Monarez, ARPA-H

Nick Seddon, Optum Genomics 

Giselle Sholler, Penn State Hershey Children’s Hospital

Janet Woodcock

Janet Woodcock, Former FDA

TRACK 2

1:50-2:50

Advancing Precision Medicine in Non-Oncology Therapeutic Areas

Moderator: Mike Montalto, Amgen

Scott Friedman, Mt. Sinai

Sana Syed, University of Virginia

Lei Zhao, Amgen

2:50-3:50

Emerging Role of Precision Medicine in Cardiovascular Disease
Daniel Rader

Daniel Rader, UPENN

3:50 – 4:20

Networking and Exhibits

TRACK 1

TRACK 2

TRACK 1

PRECISION ONCOLOGY continued

TRACK 2

PM OUTSIDE OF ONCOLOGY continued

4:20 – 6:15

TRACK 1

4:20-4:45

Precision Medicine, What’s So Difficult? The Interplay & Complexities of Delivering on the Promise of Precision Medicine
Sarah Hersey

Sarah Hersey, BMS

4:45-5:30

MRD and Its Impact on Precision Medicine Approaches

5:30-6:30

Enabling Adoption of Precision Medicine in the Clinical Setting – the Testing Gap

Allison Eck, Doylestown Health

Harry Erba, Duke Cancer Institute

Shahanawaz “DJ” Jiwani, Frederick National Lab

TRACK 2

4:20-4:45

4:45-5:30

Coming Soon

5:30-6:15

Women’s Health

Moderator: Neha Kumar, Johnson & Johnson

Oriana Papin Zoghbi, AOADx

6:30 – 7:00

Evening Keynote

Reimagining Health Equity in the Era of Precision Medicine
Rick Kittles

Rick Kittles, Morehouse School of Medicine

7:00 – 7:45

Cocktail Networking Reception and Awards

November 02, 2024

8:00-8:55

Registration and Check-in          Meeting Room 203          Philadelphia Convention Center

TRACK 1

TRACK 2

TRACK 1

PRECISION ONCOLOGY

TRACK 2

NOVEL TECHNOLOGIES in PM

8:55-9:00

Welcome and Day 1 Recap

9:00 – 9:20

Opening Keynote

Accelerating Precision Medicine Beyond Oncology

Gabriele Allegri, Johnson and Johnson 

9:20 – 11:10

9:20-9:50

How Can We Close the Clinical Practice Gaps in Precision Medicine?

Susanne Munksted, Diaceutics

9:50-10:15

Implementation of a CLIA-based Reverse Phase Protein Array Assay for Precision Oncology Applications: Proteomics and Phosphoproteomics at the Bedside

Emanuel Petricoin, George Mason University

10:15-11:10

MRD
Adrian Lee

Adrian Lee, UPMC

Marija Balic, UPMC

Muhammed, Murtaza, University of Wisconsin-Madison

9:20-9:50

Jasmine Plummer

Jasmine Plummer, St. Jude’s Children’s Research Hospital 

9:50-10:15

Uncoupling Pathways Involved in Immunotherapy Resistance: Insights from Deep Tissue Profiling
Arutha Kulasinghe

Arutha Kulsinghe, Queensland Spatial Biology Centre  

10:15-10:40

Spatial Technologies
Rong Fan

Rong Fan, Yale 

10:40-11:10

A Brief Overview of Current Advances in Spatial-Omics Technologies
Luciano Martelotto

Luciano Martelotto, University of Melbourne Centre for Cancer Research

11:10-11:40

Networking and Exhibits

TRACK 1

TRACK 2

TRACK 1

PRECISION ONCOLOGY continued

TRACK 2

NOVEL TECHNOLGIES IN PM continued

11:40 – 1:00

TRACK 1

11:40-12:35

Transcriptomics and AI in Transforming Precision Diagnosis

Maher Albitar, Genomic Testing Cooperative

Marija Balic, UPMC

Andrew Pecora, Hackensack University Medical Center 

12:35-1:00

The Impact of Multi-Omics in the Context of the APOLLO Moonshot Program

TRACK 2

11:40-12:35

Spatial Panel Discussion
Jasmine Plummer

Jasmine Plummer, St. Jude’s Children’s Research

Giovanna Prout, ScaleBio

Rong Fan

Rong Fan, Yale 

Arutha Kulasinghe

Arutha Kulsinghe, Queensland Spatial Biology Centre  

12:35-1:00

Coming Soon

1:00 – 2:00

TRACK 1

LUNCH

TRACK 2

LUNCH

1:00 – 2:00

Lunch

TRACK 1

TRACK 2

TRACK 1

PRECISION ONCOLOGY continued

TRACK 2

NOVEL TECHNOLGIES IN PM continued

2:00 – 4:50

2:00-2:30

AI in Precision Oncology

2:30-3:20

Coming Soon!

3:20-4:00

FT3

2:00-2:30

Next Phase of Gene Therapies – What the Future Holds

Stephan Grupp, CHOP

2:30-3:20

Optimizing Medium Formulation – Media Matters

Roddy O’Connor, UPENN

David Sheehan, Nucleus Biologics

Caitlin Hopper, UPENN

3:20-4:10

Accelerated Cell Therapy Manfacturing Workflows

Roddy O’Connor, UPENN

Saba Ghassemi, UPENN

Mark Garner, Agilent

REGISTRATION
OPEN

SPONSOR

Interested in sponsoring the event? Email Nigel Russell by using the link below!

Advancing Precision Medicine Middle East